Transferrin targeted nanoparticles containing temozolomide and JQ1 cross BBB in preclinical study to treat glioblastoma
|
|
BIOASIS TECHNOLOGIES INC
|
May 21, 2018 12:19PM
|
Re: IR
|
|
Resverlogix Corp.
|
Sep 25, 2017 10:43AM
|
Bioasis eyeing NASDAQ after raising $2.2M
|
|
BIOASIS TECHNOLOGIES INC
|
May 17, 2018 01:53PM
|
Re: BETonMACE top line data
|
|
Resverlogix Corp.
|
Jan 16, 2018 12:53PM
|
Angiochem's ANG1005 nearing start of Phase 3
|
|
BIOASIS TECHNOLOGIES INC
|
Dec 21, 2016 03:45PM
|
Re: RVX chasing BTI
|
|
Resverlogix Corp.
|
Sep 23, 2016 04:52PM
|
Resverlogix Advances US$30 Million Loan Closing Documentation
|
|
Resverlogix Corp.
|
May 01, 2018 08:26AM
|
biOasis Announces the Issuance of Another Key US Patent
|
|
BIOASIS TECHNOLOGIES INC
|
Nov 30, 2015 12:12PM
|
Re: Biogen/Eisai Scrap Aducanumab
|
|
Resverlogix Corp.
|
Mar 25, 2019 01:34PM
|
RESVERLOGIX EXCEEDS FULL ENROLLMENT FOR THE PIVOTAL PHASE 3 BETONMACE CLINICAL TRIAL
|
|
Resverlogix Corp.
|
Mar 19, 2018 07:39AM
|
biOasis AGM and Special Meeting set for Jan. 23, 2017
|
|
BIOASIS TECHNOLOGIES INC
|
Dec 13, 2016 04:46PM
|
Re: Zenith Meeting now posted
|
|
Resverlogix Corp.
|
Jan 15, 2016 11:36AM
|
Re: Denali Therapeutics Inc. Market Cap. $1.66 Billion today!!!
|
|
BIOASIS TECHNOLOGIES INC
|
Aug 31, 2018 09:28AM
|
Armagen reports early positive Phase II data for AGT-181
|
|
BIOASIS TECHNOLOGIES INC
|
Feb 17, 2017 11:49AM
|
Re: Patient Years & MACE rate Question
|
|
Resverlogix Corp.
|
Jul 11, 2019 01:28PM
|
Bioasis Appoints Deborah Rathjen, B.Sc. (Hons), Ph.D., MAICD, FTSE as Chair of the Board of Directors
|
|
BIOASIS TECHNOLOGIES INC
|
Mar 21, 2018 09:49AM
|
Re: BiOasis presenting at Brains for Brain 2017 meeting
|
|
BIOASIS TECHNOLOGIES INC
|
Mar 30, 2017 05:37PM
|
Re: New Share Price Contest
|
|
Resverlogix Corp.
|
Oct 11, 2019 04:53PM
|
Re: Any word on today's presentation?
|
|
Resverlogix Corp.
|
Jan 08, 2018 04:42PM
|
Re: Someone please post a link to the slides.
|
|
Resverlogix Corp.
|
Dec 06, 2019 09:19AM
|